Celltrion Archives | Be Korea-savvy
Celltrion’s Biosimilars Overtaking Originals in U.S., Europe

Celltrion’s Biosimilars Overtaking Originals in U.S., Europe

SEOUL, Apr. 27 (Korea Bizwire) — South Korea’s pharmaceutical giant Celltrion has become a strong competitor to European and U.S. drugs with its biosimilars, indicated by changes in sales, industry officials said Friday. Multinational drugmaker Roche logged a 44 percent fall in sales of Mabthera, an antibody used to treat rheumatoid arthritis, lymphoma and some [...]

Celltrion’s Truxima Drug to Sell in Colombia

Celltrion’s Truxima Drug to Sell in Colombia

SEOUL, Feb. 21 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc.’s biosimilar drug Truxima will reach the Colombian market, the company’s affiliate said Wednesday. Global drug firm Mundi Pharma Inc. won exclusive rights to distribute and market the copy of Roche’s blockbuster medicine, also known as MabThera, in the South American country, Celltrion Healthcare [...]

Drugmaker Celltrion Surpasses Hyundai Motor in Market Value

Drugmaker Celltrion Surpasses Hyundai Motor in Market Value

SEOUL, Jan. 8 (Korea Bizwire) – Drugmaker Celltrion Inc.’s stock has made significant gains in recent days, surpassing Hyundai Motor Co. in terms of market value, data showed Monday. Celltrion shares jumped 55.12 percent over the past 7 trading sessions to 302,500 won (US$283.29) on Monday closing, pushing the company’s capitalization to a record 37.1 trillion won. Hyundai Motor’s market capitalization stood at 33.2 trillion won as of Monday closing. Celltrion’s [...]

Celltrion Head Becomes 4th-richest Man in Stock Holdings in S. Korea amid Bio Boom: Data

Celltrion Head Becomes 4th-richest Man in Stock Holdings in S. Korea amid Bio Boom: Data

SEOUL, Jan. 8 (Korea Bizwire) — The head of a biotech venture firm has emerged as the fourth-richest man in stock holdings in South Korea, industry data showed Sunday, amid a bio venture boom in Asia’s fourth-biggest economy. The value of stocks held by Seo Jung-jin, chairman of biopharmaceutical firm Celltrion Inc., rose to 5.39 [...]

Private-Public Sector Cooperation Crucial for Songdo Biopharmaceuticals Hub

Private-Public Sector Cooperation Crucial for Songdo Biopharmaceuticals Hub

SEOUL, Dec. 1 (Korea Bizwire) – To maintain its status as the world’s largest biopharmaceuticals manufacturing city, voices in Songdo are calling for greater cooperation between the private and public sectors.  Leading biopharmaceuticals firms, among them Samsung Biologics and Celltrion, have made large investments in Songdo to build up the city’s manufacturing capabilities. By next [...]

Medical Research Driving Business with Over 400 Licensing Deals

Medical Research Driving Business with Over 400 Licensing Deals

SEOUL, Nov. 16 (Korea Bizwire) – Technology Licensing Offices at hospitals, universities and research labs had successfully inked 405 technology transfer deals with businesses as of October, the Ministry of Health and Welfare revealed on November 15. Technology Licensing Offices, commonly referred to as TLOs, are organizations set up as intermediaries that serve as the [...]